Clinical news & media

01/01/2021 - Press releases

Medimaps Group raises $20 million to expand and to commercialize AI product portfolio for bone health assessment utilizing routine medical images

1 2

medimaps group SA
Chemin du Champ-des-Filles 36
1228 Plan-les-Ouates
Geneva, Switzerland

Medimaps Group USA LLC
1201N Market Street
Suite 111
Wilmington, DE 19801, United States

Customer care

Instructions for use
Contact us

Medimaps Group has been certified by BSI to ISO 13485:2016 under certificate number MDR 799726. TBS iNsight is a trademark of Medimaps Group. TBS iNsight™ is cleared for sale in the U.S.